ITMCTR2200006574尚未招募1 期
The efficacy and mechanism of Yishen Paidu Formula for chronic kidney disease (stage 4 to 5): a pilot study.
Guangdong Provincial Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 85（—）
- 性别
- All
入选标准
- •? Aged =18 years;
- •? Chronic kidney disease stage 4 to 5 (non-dialysis) patients.
- •? Patients agreed to participate in the study with inform consent.
排除标准
- •? Pregnant women or patients in lactating;
- •? Patients with hyperkalemia, acute heart failure and other conditions which require initiation of dialysis;
- •? Patients who are taking glucocorticoids or immunosuppressants;
- •? Patients with inflammatory bowel disease, or patients with severe primary diseases such as active malignant tumor and gastrointestinal bleeding, or patients who cannot cooperate with treatment such as mental illness.
- •? Patients with acute infection or using antibiotics
- •? Patients who are taking probiotics, probiotics and other drugs that affect intestinal flora
- •? Patients who are allergy to the drugs used in the study.
研究者
相似试验
招募中
4 期
The effect and mechanism of Zishen Yutai Pill on IVF-ET in patients with diminished ovarian reserveITMCTR2200005713Reproductive Hospital Affiliated to Shandong University
招募中
1 期
Clinical study of Shugan Jianpi Huazhi Decoction combined with Tongluo Yanggan application in the treatment of non-alcoholic fatty liver diseaseITMCTR2022000098Guang'anmen Hospital, China Academy of Chinese Medical Sciences
招募中
1 期
Clinical study of Jianpi Yanggan Decoction combined with Tongluo Yanggan application in the treatment of autoimmune hepatitisAutoimmune HepatitisITMCTR2022000094Guang'anmen Hospital, China Academy of Chinese Medical Sciences
尚未招募
1 期
Clinical study of Qinggan Huashi Jiejiu Decoction combined with Tongluo Yanggan application in the treatment of alcoholic liver diseaseITMCTR2022000106Guang'anmen Hospital, China Academy of Chinese Medical Sciences
尚未招募
早期 1 期
A randomized, double-blind, placebo-controlled clinical study on Yinqi Sanhuang Jiedu Decoction combined with Tongluo Yanggan application in the treatment of hepatitis B-related liver fibrosisITMCTR2022000019Guang'anmen Hospital, China Academy of Chinese Medical Sciences